NFKB1 and classic Hodgkin lymphoma: In EBV-positive cHL cases (comprising ~30–40% of all diagnoses) NF-κB is activated through the viral genome-encoded LMP1 and LMP2a gene products that mimic the normal cellular CD40 and BCR signaling, respectively.